J. Nojd et al., Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype, VACCINE, 19(13-14), 2001, pp. 1727-1731
In April 1999, a previously healthy 22-year-old woman was taken ill with fe
ver and bilateral swelling of the parotid glands. A chronic course of disea
se extending from April to December was found with swelling of the parotid
glands, fatigue, low grade fever, episodes of tachycardia and nightswetting
. Mumps virus RNA of genotype A character based on the SH (small hydrophobi
c) protein gene classification was demonstrated in three serum samples coll
ected during the course of clinical disease. Different criteria for reinfec
tion were fulfilled including demonstration of IgG antibodies by ELISA in a
preinfection serum sample. The preinfection serum sample of the patient wa
s able to efficiently neutralize the infectivity of a heterologous genotype
D strain but was unable to neutralize the homologous genotype A virus. The
findings in the present study may offer an explanation of a mechanism behi
nd previously observed vaccine failures and the occurrence of reinfection w
ith heterologous mumps virus strains. (C) 2001 Elsevier Science Ltd. All ri
ghts reserved.